Niu, Ruilong
Jiang, Yujuan
Bi, Zhibing
Zhang, Huiping
Mei, Xianghuang
Bi, Jianjun
Xing, Wei
Guo, Wei
Liang, Jianwei
Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2022L01)
Article History
Received: 15 September 2023
Accepted: 25 July 2024
First Online: 9 August 2024
Declarations
:
: All enrolled patients sign written informed consent to participate in the study. The study was conducted per STARD reporting guidelines. All the procedures followed the ethical standards of the World Medical Association Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of the National Cancer Center/Cancer Hospital, the Chinese Academy of Medical Science, and Peking Union Medical College, and affiliated Heji Hospital of Changzhi Medical College (LA2016-22-01).
: Not applicable.
: Authors have no conflicts of interest or financial ties to disclose.